Neoadjuvant therapy in pancreatic neuroendocrine neoplasms: A systematic review and meta-analysis.

Li, Yongzheng; Fan, Zhiyao; Zhang, Feifei; Yang, Jian; Shi, Ming; Liu, Shujie; Meng, Yufan; Zhan, Hanxiang

Li, Yongzheng; Fan, Zhiyao; Zhang, Feifei; Yang, Jian; Shi, Ming; Liu, Shujie; Meng, Yufan; Zhan, Hanxiang.

Afiliação

Li Y; Division of Pancreatic Surgery, Department of General Surgery, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Fan Z; Division of Pancreatic Surgery, Department of General Surgery, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Zhang F; The First Operating Theater, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Yang J; Division of Pancreatic Surgery, Department of General Surgery, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Shi M; Division of Pancreatic Surgery, Department of General Surgery, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Liu S; Division of Pancreatic Surgery, Department of General Surgery, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Meng Y; Division of Pancreatic Surgery, Department of General Surgery, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Zhan H; Division of Pancreatic Surgery, Department of General Surgery, Qilu Hospital, Shandong University, Jinan, Shandong, China.

Front Oncol ; 12: 981575, 2022.

Article em En | MEDLINE | ID: mdl-36505835

Palavras-chave

neoadjuvant therapy; pancreatic neuroendocrine tumor; prognosis; surgery; tumor response

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google